These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 30397059)
21. Antibacterial activity of human simulated epithelial lining fluid concentrations of amikacin inhale alone and in combination with meropenem against Acinetobacter baumannii. Ghazi IM; Grupper M; Nicolau DP Infect Dis (Lond); 2017; 49(11-12):831-839. PubMed ID: 28758820 [TBL] [Abstract][Full Text] [Related]
23. In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii clinical isolates. Ricciardi R; Ricciardi AM; Danzi G Infez Med; 2009 Dec; 17(4):236-9. PubMed ID: 20046104 [TBL] [Abstract][Full Text] [Related]
24. Cationic amphiphilic alpha-helical peptides for the treatment of carbapenem-resistant Acinetobacter baumannii infection. Huang Y; Wiradharma N; Xu K; Ji Z; Bi S; Li L; Yang YY; Fan W Biomaterials; 2012 Dec; 33(34):8841-7. PubMed ID: 22925814 [TBL] [Abstract][Full Text] [Related]
25. Activity of tigecycline (GAR-936) against Acinetobacter baumannii strains, including those resistant to imipenem. Pachón-Ibáñez ME; Jiménez-Mejías ME; Pichardo C; Llanos AC; Pachón J Antimicrob Agents Chemother; 2004 Nov; 48(11):4479-81. PubMed ID: 15504889 [TBL] [Abstract][Full Text] [Related]
26. Multidrug-resistant Acinetobacter baumannii pneumonia in lung transplant recipients. Sopirala MM; Pope-Harman A; Nunley DR; Moffatt-Bruce S; Ross P; Martin SI J Heart Lung Transplant; 2008 Jul; 27(7):804-7. PubMed ID: 18582814 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of tigecycline/colistin combination in a pneumonia model caused by extensively drug-resistant Acinetobacter baumannii. Mutlu Yilmaz E; Sunbul M; Aksoy A; Yilmaz H; Guney AK; Guvenc T Int J Antimicrob Agents; 2012 Oct; 40(4):332-6. PubMed ID: 22831842 [TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic and Pharmacodynamic Profiling of Minocycline for Injection following a Single Infusion in Critically Ill Adults in a Phase IV Open-Label Multicenter Study (ACUMIN). Lodise TP; Van Wart S; Sund ZM; Bressler AM; Khan A; Makley AT; Hamad Y; Salata RA; Silveira FP; Sims MD; Kabchi BA; Saad MA; Brown C; Oler RE; Fowler V; Wunderink RG Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33168615 [TBL] [Abstract][Full Text] [Related]
29. In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates. Tan TY; Ng LS; Tan E; Huang G J Antimicrob Chemother; 2007 Aug; 60(2):421-3. PubMed ID: 17540671 [TBL] [Abstract][Full Text] [Related]
31. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii. Navon-Venezia S; Leavitt A; Carmeli Y J Antimicrob Chemother; 2007 Apr; 59(4):772-4. PubMed ID: 17353223 [TBL] [Abstract][Full Text] [Related]
32. Biofilm prevention concentrations (BPC) of minocycline compared to polymyxin B, meropenem, and amikacin against Acinetobacter baumannii. Beganovic M; Luther MK; Daffinee KE; LaPlante KL Diagn Microbiol Infect Dis; 2019 Jul; 94(3):223-226. PubMed ID: 30827805 [TBL] [Abstract][Full Text] [Related]
33. Rapid development of Acinetobacter baumannii resistance to tigecycline. Reid GE; Grim SA; Aldeza CA; Janda WM; Clark NM Pharmacotherapy; 2007 Aug; 27(8):1198-201. PubMed ID: 17655518 [TBL] [Abstract][Full Text] [Related]
34. Update on Acinetobacter species: mechanisms of antimicrobial resistance and contemporary in vitro activity of minocycline and other treatment options. Castanheira M; Mendes RE; Jones RN Clin Infect Dis; 2014 Dec; 59 Suppl 6():S367-73. PubMed ID: 25371512 [TBL] [Abstract][Full Text] [Related]
36. Clinical experience of tigecycline treatment in infections caused by extensively drug-resistant Acinetobacter spp. Moon SY; Peck KR; Chang HH; Kim SW; Heo ST; Son JS; Ryu SY; Moon C; Jung SI; Shin SY; Lee JA; Joung MK; Chung DR; Kang CI; Song JH Microb Drug Resist; 2012 Dec; 18(6):562-6. PubMed ID: 22775562 [TBL] [Abstract][Full Text] [Related]
37. Minocycline activity tested against Acinetobacter baumannii complex, Stenotrophomonas maltophilia, and Burkholderia cepacia species complex isolates from a global surveillance program (2013). Flamm RK; Castanheira M; Streit JM; Jones RN Diagn Microbiol Infect Dis; 2016 Jul; 85(3):352-355. PubMed ID: 27112832 [TBL] [Abstract][Full Text] [Related]
38. Efficacy of Lysophosphatidylcholine in Combination with Antimicrobial Agents against Acinetobacter baumannii in Experimental Murine Peritoneal Sepsis and Pneumonia Models. Parra Millán R; Jiménez Mejías ME; Sánchez Encinales V; Ayerbe Algaba R; Gutiérrez Valencia A; Pachón Ibáñez ME; Díaz C; Pérez Del Palacio J; López Cortés LF; Pachón J; Smani Y Antimicrob Agents Chemother; 2016 Aug; 60(8):4464-70. PubMed ID: 27161639 [TBL] [Abstract][Full Text] [Related]
39. Minocycline: an old drug for a new bug: multidrug-resistant Acinetobacter baumannii. Goff DA; Kaye KS Clin Infect Dis; 2014 Dec; 59 Suppl 6():S365-6. PubMed ID: 25371511 [No Abstract] [Full Text] [Related]
40. Comparison of tigecycline penetration into the epithelial lining fluid of infected and uninfected murine lungs. Crandon JL; Kim A; Nicolau DP J Antimicrob Chemother; 2009 Oct; 64(4):837-9. PubMed ID: 19696049 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]